IBI Group acquires GreenOwl Mobile
IBI Group (TSX: IBG) closed the asset purchase of Ontario-based GreenOwl Mobile, including all intellectual property from Matt Man
Regions
Second Cup closes $10M bought deal financing
The Second Cup Ltd. (TSX: SCU) closed its short form prospectus offering of 2,898,600 common shares at $3.45 for gross proceeds of $10,000,170. Clarus Securities Inc. acted as sole underwriter and bookrunner.
Maple Leaf Green World announces $20M private placement
Maple Leaf Green World (NEO: MGW; OTCQB: MGWFF) engaged Emerging Equities Inc. for a brokered private placement financing for gross proceeds of a minimum of $1,000,000 and a maximum of $20,000,000
Akumin completes US $35M bought deal financing
Akumin Inc. (TSX: AKU.U) completed bought deal offering of 8,750,000 common shares at US $4.00 for gross proceeds of US $35,000,000. Clarus Securities Inc. led the offering.
Millennial Esports secures US $10M facility with Eastmore Global
Millennial Esports (TSX-V: GAME; OTCQB: MLLLF) entered into an agreement for a US $10M revolving multi-draw credit facility with Eastmore Global Ltd., with initial drawdown under the facility being US $1.1M
Emblem invests $2.5 million in Fire & Flower
Emblem Corp. (TSX-V:EMC) (EMC.WT) acquired $2.5 million of units of Fire & Flower Inc. at $0.80 per unit as part of a larger Unit offering conducted by Fire & Flower.
Goodfood Market announces $10M bought deal
Goodfood Market (TSX: FOOD) engaged GMP Securities L.P. for a bought deal of 4 million common shares at $2.50 per shares for gross proceeds of approximately $10 million
Block X Capital invests in Abaxx Technologies and Buildingsblock Technologies
Block X Capital (CSE: BXXX) invested $250,000 in Abaxx Technologies Inc. and $157,500 in Buildingsblock Technologies Corp.
AcuityAds Holdings closes $4.6M bought deal
AcuityAds Holdings Inc. (TSX-V:AT) closed bought deal private placement of 4,600,000 shares at $1.00 for gross proceeds of $4.6 million. Haywood Securities Inc. led the offering
MPX Bioceutical to acquire Canveda for $18M
MPX Bioceutical (CSE: MPX, OTC: MPXEF) to acquire 100% of the issued and outstanding shares of Canveda Inc. for a total purchase price of CDN $18 million
